Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: A 4-year case-controlled study

Diabetes Care

Volumn 28, Issue 11, 2005, Pages 2703-2709

  Pontiroli, Antonio E ^a,b   Folli, Franco ^c   Paganelli, Michele ^c   Micheletto, Giancarlo ^d   Pizzocri, Pierluigi ^a,b   Vedani, Paola ^c   Luisi, Francesca ^c   Perego, Lucia ^c   Morabito, Alberto ^a   Doldi, Santo Bressani ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale San Paolo   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d ISTITUTO CLINICO SANT'AMBROGIO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CONTROLLED STUDY; DIET; DISEASE COURSE; DISEASE SEVERITY; FAT CONTENT; FEMALE; FOLLOW UP; GASTRIC BANDING; HUMAN; HYPERTENSION; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MENTAL TEST; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PROPHYLAXIS; PSYCHOLOGIC TEST; REMISSION; WEIGHT REDUCTION; CASE CONTROL STUDY; COMPARATIVE STUDY; GASTROPLASTY; ITALY; LAPAROSCOPY; METABOLISM; METHODOLOGY; MIDDLE AGED; MORBID OBESITY; PREVALENCE; TIME; TREATMENT OUTCOME;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GASTROPLASTY; HUMANS; HYPERTENSION; ITALY; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; PREVALENCE; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 29544436856     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.28.11.2703     Document Type: Article

References (40)

1. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, Speizer FE, Hennekens CH: A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 322:882-889, 1990
2. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr: Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097-1105, 1999
3. Bjorntorp P: Metabolic implications of body fat distribution. Diabetes Care 14: 1132-1143, 1991
4. Licata G, Scaglione R, Paterna S, Parrinello G, Indovina A, Dichiara MA, Alaimo G, Merlino G: Left ventricular function response to exercise in normotensive obese subjects: influence of degree and duration of obesity. Int J Cardiol 37: 223-230, 1992
5. Everhart JE, Pettitt DJ, Bennett PH, Knowler WC: Duration of obesity increases the incidence of NIDDM. Diabetes 41:235-240, 1992
6. Pontiroli AE, Galli L: Duration of obesity is a risk factor for non-insulin-dependent diabetes mellitus, not for arterial hypertension or for hyperlipidemia. Acta Diabetol 35:130-136, 1998
7. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319:1500-1506, 1988
8. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
9. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, the Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
10. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP: Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796-2803, 2002
11. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, the STOP-NIDDM Trial Research Group: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072-2077, 2002
12. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L: XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27:155-161, 2004
13. Diabetes Prevention Program Research Group: Effects of withdrawal from met-formin on the development of diabetes in the diabetes prevention program. Diabetes Care 26:977-980, 2003
14. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, the STOP-NIDDM Trial Research Group: Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290:486-494, 2003
15. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
16. Grassi G, Seravalle G, Dell'Oro R: Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 36: 538-542, 2000
17. Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlof B, the LIFE Study Group: Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients: the losartan intervention for endpoint (LIFE) reduction in hypertension study. Hypertension 35:13-18, 2000
18. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS: Obesity and the risk of heart failure. N Engl J Med 347:305-313, 2002
19. National Institutes of Health: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 6 (Suppl. 2):51S-209S, 1998
20. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM: Whowould have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339-350, 1995
21. Pontiroli AE, Pizzocri P, Librenti MC, Vedani P, Marchi M, Cucchi E, Orena C, Paganelli M, Giacomelli M, Ferla G, Folli F: Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 87:3555-3561, 2002
22. Dixon JB, O'Brien PE: Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 25:358 -363, 2002
23. Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A: Biliopancreatic diversion. World J Surg 22: 936-946, 1998
24. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K: Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724-1737, 2004
25. Chapman AE, Kiroff G, Game P, Foster B, O'Brien P, Ham J, Maddern GJ: Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 135:326-351, 2004
26. Long SD, O'Brien K, MacDonald KG Jr, Leggett-Frazier N, Swanson MS, Pories WJ, Caro JF: Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes: a longitudinal interventional study. Diabetes Care 17:372-375, 1994
27. Sjostrom CD, Peltonen M, Wedel H, Sjostrom L: Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 36:20 -25, 2000
28. World Health Organization: Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Committee. Geneva, World Health Org., 1995 (Tech. Rep. Ser., no. 854)
29. Mazure CM, Halmi KA, Sunday SR, Romano SJ, Einhorn AM: The Yale-Brown-Cornell Eating Disorder Scale: development, use, reliability and validity. J Psychiatr Res 28:425- 445, 1994
30. Robins LN, Helzer JE, Croughan J, Ratcliff KS: National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen Psychiatry 38:381-389, 1981
31. Alberti KGMM, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 15:539 -553, 1998
32. The DCCT Research Group: Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. Clin Chem 33:2267-2271, 1987
33. Kotler DP, Burastero S, Wang J, Pierson RN Jr: Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease. Am J Clin Nutr 64 (Suppl.):489S-497S, 1996
34. Bhat DS, Yajnik CS, Sayyad MG, Raut KN, Lubree HG, Rege SS, Chougule SD, Shetty PS, Yudkin JS, Kurpad AV: Body fat measurement in Indian men: comparison of three methods based on a two-compartment model. Int J Obes Relat Metab Disord 29:842-848, 2005
35. Lubrano C, Cornoldi A, Pili M, Falcone S, Brandetti F, Fabbrini E, Ginanni-Corradini S, Eramo A, Marini M, Migliaccio S, Giancotti V, Badiali M, Falsetto N, Prossomariti G, Spera G: Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years' follow-up. Int J Obes Relat Metab Disord 28:1600-1606, 2004
36. Fox CS, Sullivan L, D'Agostino RB Sr, Wilson PW: The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care 27:704 -708, 2004
37. MacDonald KG Jr, Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, Pories WJ: The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1:213-220, 1997
38. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP, MacLean LD: Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240:416-423, 2004
39. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM: Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291:2847-2850, 2004
40. Denzer C, Reithofer E, Wabitsch M, Widhalm K: The outcome of childhood obesity management depends highly upon patient compliance. Eur J Pediatr 163:99 -104, 2004